Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 9/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.61 |
| ▸ | CDC25B | P30305 | 7/20 | 0.61 |
| ▸ | MEN1 | O00255 | 6/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.61 |
| ▸ | CDC25A | P30304 | 6/20 | 0.61 |
| ▸ | LMNA | P02545 | 6/20 | 0.61 |
| ▸ | HPGD | P15428 | 5/20 | 0.61 |
| ▸ | BLM | P54132 | 5/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.61 |
| ▸ | TP53 | P04637 | 5/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.61 |
| ▸ | IDO1 | P14902 | 3/20 | 0.61 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.61 |
| ▸ | PKM | P14618 | 2/20 | 0.61 |
| ▸ | HSPD1 | P10809 | 2/20 | 0.61 |
| ▸ | HSPE1 | P61604 | 2/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30715504 | 0.93 | CDC25B (0.57) | MAPTALDH1A1CDC25BMEN1KMT2A | |
| SCHEMBL8773107 | 0.93 | CDC25B (0.57) | MAPTALDH1A1CDC25BMEN1KMT2A | |
| Formic Acid SCHEMBL31606783 | 0.90 | MAPT (0.52) | MAPTALDH1A1CDC25BMEN1KMT2A | |
| SCHEMBL7270394 | 0.79 | — | — | |
| SCHEMBL19415819 | 0.79 | MAPT (0.61) | MAPTALDH1A1CDC25BMEN1KMT2A | |
| SCHEMBL395231 | 0.77 | MEN1 (0.47) | MAPTALDH1A1CDC25BMEN1KMT2A | |
| SCHEMBL7146635 | 0.76 | CDC25B (0.68) | MAPTALDH1A1CDC25BMEN1KMT2A | |
| Menadione SCHEMBL25970 | 0.76 | MAPT (1.00) | MAPTALDH1A1CDC25BMEN1KMT2A | |
| Menadione SCHEMBL1364028 | 0.76 | MAPT (1.00) | MAPTALDH1A1CDC25BMEN1KMT2A | |
| Menadione SCHEMBL19356853 | 0.76 | MAPT (1.00) | MAPTALDH1A1CDC25BMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115124878-B | Manufacturing method of rubber rain shoes with chameleon effect | 杭州星发彩印有限公司 | 2023-08-22 | — | — | CN | claimed |
| CN-113355028-A | Light-cured material, display panel and preparation method thereof | 深圳市华星光电半导体显示技术有限公司 | 2021-09-07 | — | — | CN | claimed |
| CN-104710256-B | Cheap and efficient synthesis method of alpha-hydroxyketone compound | 北京大学 | 2017-03-22 | — | — | CN | claimed |
| CN-104710256-A | Cheap and efficient synthesis method of alpha-hydroxyketone compound | UNIV BEIJING | 2015-06-17 | — | — | CN | claimed |
| CN-114685703-B | Catalyst compositions comprising fluorided supports and methods of use thereof | 埃克森美孚化学专利公司 | 2026-05-12 | — | — | CN | disclosed |
| US-20250296912-A1 | AFFINITY ILLUDOFULVENE CONJUGATES | Illudent, Inc. (US) | 2025-09-25 | — | — | US | disclosed |
| US-12269793-B2 | Affinity illudofulvene conjugates | AF CHEMICALS, LLC (US) | 2025-04-08 | — | — | US | disclosed |
| CN-119306612-A | Preparation method of trans-aminoindan | 中国科学院大连化学物理研究所 | 2025-01-14 | — | — | CN | disclosed |
| CN-116143602-B | Indenone and indazolone derivatives with antioxidant activity, and synthetic method and application thereof | 西南大学 | 2024-10-22 | — | — | CN | disclosed |
| CN-117551023-A | Preparation method and application of N-thio-phenyl phthalimide compound | 太原理工大学 | 2024-02-13 | — | — | CN | disclosed |
| CN-115124878-B | Manufacturing method of rubber rain shoes with chameleon effect | 杭州星发彩印有限公司 | 2023-08-22 | — | — | CN | disclosed |
| CN-116554104-A | Indenone and indazolone derivatives with antioxidant activity, and synthetic method and application thereof | 西南大学 | 2023-08-08 | — | — | CN | disclosed |
| WO-2004034963-A2 | METHODS AND COMPOSITIONS USING CHOLINESTERASE INHIBITORS | EISAI CO., LTD. (JP) | 2004-04-29 | — | — | WO | disclosed |
| WO-2003092606-A2 | CHOLINESTERASE INHIBITORS TO PREVENT INJURIES CAUSED BY CHEMICALS | EISAI CO., LTD. (JP) | 2003-11-13 | — | — | WO | disclosed |
| WO-2003024456-A1 | METHODS FOR TREATING AND PREVENTING MIGRAINES | EISAI CO., LTD. (JP) | 2003-03-27 | — | — | WO | disclosed |
| US-6268444-B1 | TITANIUM, ZIRCONIUM OR HAFNIUM COMPOUNDS FOR POLYMERIZATION | DOW CHEMICAL COMPANY | 2001-07-31 | — | — | US | disclosed |
| EP-0789680-A1 | PROCESS FOR PREPARING CYCLIC KETONES | HOECHST CELANESE CORPORATION (US) | 1997-08-20 | — | — | EP | disclosed |
| WO-1996014284-A1 | PROCESS FOR PREPARING CYCLIC KETONES | HOECHST CELANESE CORPORATION (US) | 1996-05-17 | — | — | WO | disclosed |
| US-5489712-A | METHYLENATING SUBSTITUTED KETONE TO FORM ALPHA, BETA UNSATURATED KETONE, CYCLIZING IN PRESENCE OF ACID OR BASE | HOECHST CELANESE CORPORATION (US) | 1996-02-06 | — | — | US | disclosed |
| US-3976634-A | ANTIINFLAMMATORY | SANDOZ, INC. (US) | 1976-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250296912-A1 | AFFINITY ILLUDOFULVENE CONJUGATES | OGFR, TNFSF11, FCER2 | MAPT 2405/4885ALDH1A1 4400/4885CDC25B 3373/4885 |
| US-12269793-B2 | Affinity illudofulvene conjugates | OGFR, TNFSF11, FCER2 | MAPT 2405/4885ALDH1A1 4400/4885CDC25B 3373/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.